Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001902368-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 16, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
22,233
Total Value
$345,893.27
P&L
+inf% (+$571,480.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Apr 13, 2026 | Grant/Award | 14,000 | $0.00 | $0.00 | 119,706 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Apr 14, 2026 | Sale | 7,215 | $41.93 | $302,516.29 | 112,491 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Apr 15, 2026 | Sale | 1,018 | $42.61 | $43,376.98 | 111,473 | Direct | โ | View Details |